By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Exonhit today said that Almac Diagnostics will serve as the sole reference laboratory for testing performed with Exonhit's AclarusDx for Alzheimer's disease.
Registering provides access to this and other free content.
Already have an account?Login Now.
The new Riken president outlines some of his plans for the institute.
The Guardian discusses whether big science projects are worth the loss of resources available for other scientific pursuits.
An NEJM update from the ClinVar team highlights the difficulties of interpreting genetic variants.
In Nature this week: genomic analysis of high-grade serous ovarian cancer, and more.